Diabetes and coronary artery disease: time to stop taking the tablets?

被引：10

作者：

Connaughton, M ^{[1
]}

Webber, J

机构：

[1] Univ Birmingham, Queen Elizabeth Hosp, NHS Trust, Dept Cardiol, Birmingham B15 2TH, W Midlands, England

[2] Univ Birmingham, Queen Elizabeth Hosp, NHS Trust, Dept Med, Birmingham B15 2TH, W Midlands, England

来源：

HEART | 1998年 / 80卷 / 02期

关键词：

D O I：

10.1136/hrt.80.2.108

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：108 / 109

页数：2

共 18 条

[1] Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction [J].

Aronson, D ;

Rayfield, EJ ;

Chesebro, JH .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (04) :296-306

[2] ISCHEMIC PRECONDITIONING ATTENUATES ACIDOSIS AND POSTISCHEMIC DYSFUNCTION IN ISOLATED RAT-HEART [J].

ASIMAKIS, GK ;

INNERSMCBRIDE, K ;

MEDELLIN, G ;

CONTI, VR .

AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :H887-H894

[3] Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].

Boden, G .

DIABETES, 1997, 46 (01) :3-10

[4]

Connaughton Mark, 1997, P159

[5] Sulfonylurea K-ATP blockade in type II diabetes and preconditioning in cardiovascular disease - Time for reconsideration [J].

Engler, RL ;

Yellon, DM .

CIRCULATION, 1996, 94 (09) :2297-2301

[6]

Gross GJ, 1996, BASIC RES CARDIOL, V91, P31

[7]

HENG MK, 1977, BRIT HEART J, V39, P748, DOI 10.1136/hrt.39.7.748

[8]

HOFFMANN D, 1993, EUR HEART J, V14, P1585

[9] Preconditioning the human myocardium: Recent advances and aspirations for the development of a new means of cardioprotection in clinical practice [J].

Jenkins, DP ;

Steare, SE ;

Yellon, DM .

CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (06) :739-747

[10] PROGNOSIS OF ACUTE MYOCARDIAL-INFARCTION IN DIABETIC AND NONDIABETIC PATIENTS [J].

KARLSON, BW ;

HERLITZ, J ;

HJALMARSON, A .

DIABETIC MEDICINE, 1993, 10 (05) :449-454

← 1 2 →